INDIA IMMUNO ONCOLOGY DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 - 2028)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Type
     • Market Snippet, By Cancer Type
     • Market Snippet, By Distribution Channels
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Cancer Analysis
   • Cancer Epidemiology
   • Key Challenges
   • Similar Biologics Approved And Marketed In India
   • Patient Population
   • Key Developments
   • Regulatory Scenario
   • Adoptive T Cell Therapies
   • PEST Analysis
   • Porter’s Five Forces Analysis

4. India Immuno-Oncology Drugs Market– Impact of Coronavirus (Covid-19) Pandemic

   • Overall Impact of COVID-19 on Healthcare market
   • COVID-19 Epidemiology

5. India Immuno-Oncology Drugs Market, By Drug Type, 2021 – 2028, (US$ Mn)

   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Immune Checkpoint Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
       • Nivolumab
       • Atezolimumab
       • Pembrolizumab
       • Durvalumab
   • Monoclonal Antibodies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
       • Rituximab
       • Trastazumab
       • Bevacizumab
       • Nimotuzumab
       • Pertuzumab
       • Ado-Trastuzumab Emtansine
   • Cancer Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
       • Gardasil
       • Cervarix

6. India Immuno-Oncology Drugs Market, By Cancer Type, 2021 – 2028, (US$ Mn)

   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Lung cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Blood cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Breast cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Ovarian cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Cervical cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Colorectal cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Stomach cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Head & Neck cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)

7. India Immuno-Oncology Drugs Market, By Distribution Channel, 2021 – 2028, (US$ Mn)

   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)

8. Competitive Landscape

   • Heat Map Analysis
   • Market Share Analysis
     • Amgen, Inc.
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • F. Hoffmann-La Roche AG
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • Intas Pharmaceuticals Ltd.
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • AstraZeneca plc
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • Mylan N.V.
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • Dr. Reddy's Laboratories
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • Bristol - Myers Squibb
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • Merck & Co., Inc.
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • BIOCAD-Biotechnology Company
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • Reliance Life Sciences
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • Biocon Limited
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies
     • Hetero Drugs Limited
       • Company highlights
       • Product Portfolio
       • Key Highlights
       • Financial performance
       • Strategies

9. Section

   • References
   • Research Methodology
   • About us and Sales Contact

*Browse 5 market data tables and 20 figures on "India Immuno-Oncology Drugs Market” – India forecast to 2028